1. Università degli Studi di Roma Tor Vergata
Indietro

Paolo Sbraccia

Qualifica
ORDINARIO
Fonte dei dati: Archivio della Ricerca http://art.torvergata.it
  1. Busetto, L., Carbonelli, M.G., Caretto, A., Colao, A., Cricelli, C., De Luca, M., et al. (2022). Updating obesity management strategies: an audit of Italian specialists. EATING AND WEIGHT DISORDERS [10.1007/s40519-022-01402-w]. Dettagli
  2. Guglielmi, V., Colangeli, L., Scipione, V., Ballacci, S., Di Stefano, M., Hauser, L., et al. (2022). Inflammation, underweight, malignancy and a marked catabolic state as predictors for worse outcomes in COVID-19 patients with moderate-to-severe disease admitted to Internal Medicine Unit. PLOS ONE, 17(5), e0268432 [10.1371/journal.pone.0268432]. Dettagli
  3. Busetto, L., Sbraccia, P., & Vettor, R. (2021). Obesity management: at the forefront against disease stigma and therapeutic inertia. EATING AND WEIGHT DISORDERS [10.1007/s40519-021-01217-1]. Dettagli
  4. Guglielmi, V., Colangeli, L., D'Adamo, M., & Sbraccia, P. (2021). Susceptibility and Severity of Viral Infections in Obesity: Lessons from Influenza to COVID-19. Does Leptin Play a Role?. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 22(6), 1-20 [10.3390/ijms22063183]. Dettagli
  5. Sbraccia, P., D'Adamo, M., & Guglielmi, V. (2021). Is type 2 diabetes an adiposity-based metabolic disease? From the origin of insulin resistance to the concept of dysfunctional adipose tissue. EATING AND WEIGHT DISORDERS [10.1007/s40519-021-01109-4]. Dettagli
  6. Carruba, M.O., Busetto, L., Bryant, S., Caretto, A., Farpour-Lambert, N.J., Fatati, G., et al. (2021). The European Association for the Study of Obesity (EASO) Endorses the Milan Charter on Urban Obesity. OBESITY FACTS, 1-6 [10.1159/000514218]. Dettagli
  7. Alfadda, A.A., Caterson, I.D., Coutinho, W., Cuevas, A., Dicker, D., Halford, J., et al. (2021). The 3Ds - Discussion, diagnosis and direction: elements for effective obesity care by healthcare professionals. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 91, 17-25 [10.1016/j.ejim.2021.01.012]. Dettagli
  8. Dicker, D., Alfadda, A.A., Coutinho, W., Cuevas, A., Halford, J., Hughes, C.A., et al. (2021). Patient motivation to lose weight: importance of healthcare professional support, goals and self-efficacy. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 91, 10-16 [10.1016/j.ejim.2021.01.019]. Dettagli
  9. Lombardo, M., Franchi, A., Biolcati Rinaldi, R., Rizzo, G., D'Adamo, M., Guglielmi, V., et al. (2021). Long-Term Iron and Vitamin B12 Deficiency Are Present after Bariatric Surgery, Despite the Widespread Use of Supplements. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 18(9), 4541 [10.3390/ijerph18094541]. Dettagli
  10. Murdocca, M., Spitalieri, P., De Masi, C., Udroiu, I., Marinaccio, J., Sanchez, M., et al. (2021). Functional analysis of POLD1 p.ser605del variant: the aging phenotype of MDPL syndrome is associated with an impaired DNA repair capacity. AGING, 13(4), 4926-4945. Dettagli
  11. Sbraccia, P., Busetto, L., Santini, F., Mancuso, M., Nicoziani, P., & Nicolucci, A. (2021). Misperceptions and barriers to obesity management: Italian data from the ACTION-IO study. EATING AND WEIGHT DISORDERS, 26(3), 817-828 [10.1007/s40519-020-00907-6]. Dettagli
  12. Von Schnurbein, J., Adams, C., Akinci, B., Ceccarini, G., D'Apice, M.R., Gambineri, A., et al. (2020). European lipodystrophy registry: background and structure. ORPHANET JOURNAL OF RARE DISEASES, 15(1) [10.1186/s13023-020-1295-y]. Dettagli
  13. Pacifici, F., Farias, C., Rea, S., Capuani, B., Feraco, A., Coppola, A., et al. (2020). Tyrosol may prevent obesity by inhibiting adipogenesis in 3T3-L1 preadipocytes. OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 1-12 [10.1155/2020/4794780]. Dettagli
  14. Arriga, R., Pacifici, F., Capuani, B., Coppola, A., Orlandi, A., Scioli, M.G., et al. (2019). Peroxiredoxin 6 Is a Key Antioxidant Enzyme in Modulating the Link between Glycemic and Lipogenic Metabolism. OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2019, 9685607 [10.1155/2019/9685607]. Dettagli
  15. Arriga, R., Pacifici, F., Capuani, B., Coppola, A., Orlandi, A., Scioli, M.G., et al. (2019). Peroxiredoxin 6 Is a Key Antioxidant Enzyme in Modulating the Link between Glycemic and Lipogenic Metabolism. OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2019, 9685607 [10.1155/2019/9685607]. Dettagli
  16. Caterson, I.d., Alfadda, A.a., Auerbach, P., Coutinho, W., Cuevas, A., Dicker, D., et al. (2019). Gaps to bridge: Misalignment between perception, reality and actions in obesity. DIABETES, OBESITY AND METABOLISM, 21(8), 1914-1924 [10.1111/dom.13752]. Dettagli
  17. Lombardo, M., Franchi, A., Padua, E., Guglielmi, V., D'Adamo, M., Annino, G., et al. (2019). Potential Nutritional Deficiencies in Obese Subjects 5 Years after Bariatric Surgery. BARIATRIC SURGICAL PRACTICE AND PATIENT CARE, 14(3), 125-130 [10.1089/bari.2019.0009]. Dettagli
  18. Pacifici, F., Della Morte, D., Capuani, B., Pastore, D., Bellia, A., Sbraccia, P., et al. (2019). Peroxiredoxin6, a Multitask Antioxidant Enzyme Involved in the Pathophysiology of Chronic Noncommunicable Diseases. ANTIOXIDANTS & REDOX SIGNALING, 30(3), 399-414 [10.1089/ars.2017.7427]. Dettagli
  19. Spitalieri, P., Talarico, R., Murdocca, M., De Masi, C., Campione, E., Serafino, A., et al. (2019). Generation of patient-specific hiPSCs model to study POLD1-related MDPL syndrome. EUROPEAN JOURNAL OF HUMAN GENETICS, 27, 549-550. Dettagli
  20. Cardellini, M., Ballanti, M., Davato, F., Cardolini, I., Guglielmi, V., Rizza, S., et al. (2018). 2-hydroxycaproate predicts cardiovascular mortality in patients with atherosclerotic disease. ATHEROSCLEROSIS, 277, 179-185 [10.1016/j.atherosclerosis.2018.06.014]. Dettagli
  21. Guglielmi, V., & Sbraccia, P. (2018). Obesity phenotypes: depot-differences in adipose tissue and their clinical implications. EATING AND WEIGHT DISORDERS, 23(1), 3-14 [10.1007/s40519-017-0467-9]. Dettagli
  22. Guglielmi, V., & Sbraccia, P. (2018). Type 2 diabetes: Does pancreatic fat really matter?. DIABETES/METABOLISM RESEARCH AND REVIEWS, 34(2), e2955 [10.1002/dmrr.2955]. Dettagli
  23. Guglielmi, V., Bellia, A., Bianchini, E., Medea, G., Cricelli, I., Sbraccia, P., et al. (2018). Drug interactions in users of tablet vs. oral liquid levothyroxine formulations: a real-world evidence study in primary care. ENDOCRINE, 59(3), 585-592 [10.1007/s12020-017-1412-4]. Dettagli
  24. Guglielmi, V., Bellia, A., Gentileschi, P., Lombardo, M., D'Adamo, M., Lauro, D., et al. (2018). Parathyroid hormone in surgery-induced weight loss: no glucometabolic effects but potential adaptive response to skeletal loading. ENDOCRINE, 59(2), 288-295 [10.1007/s12020-017-1477-0]. Dettagli
  25. Sbraccia, P., Nisoli, E., & Barazzoni, R. (2018). Obesity: focus on ongoing multidisciplinary and comprehensive research. EATING AND WEIGHT DISORDERS, 23(1), 1-1 [10.1007/s40519-017-0462-1]. Dettagli
  26. Pastore, D., Pacifici, F., Capuani, B., Palmirotta, R., Dong, C., Coppola, A., et al. (2017). Sex-Genetic Interaction in the Risk for Cerebrovascular Disease. CURRENT MEDICINAL CHEMISTRY, 24(24), 2687-2699 [10.2174/0929867324666170417100318]. Dettagli
  27. Guglielmi, V., D'Adamo, M., Menghini, R., Cardellini, M., Gentileschi, P., Federici, M., et al. (2017). MicroRNA 21 is up-regulated in adipose tissue of obese diabetic subjects. NUTRITION AND HEALTHY AGING, 4(2), 141-145 [10.3233/NHA-160020]. Dettagli
  28. Colao, A., Lucchese, M., D'Adamo, M., Savastano, S., Facchiano, E., Veronesi, C., et al. (2017). Healthcare usage and economic impact of non-treated obesity in Italy: findings from a retrospective administrative and clinical database analysis. BMJ OPEN, 7(2), e013899 [10.1136/bmjopen-2016-013899]. Dettagli
  29. Barazzoni, R., Deutz, N., Biolo, G., Bischoff, S., Boirie, Y., Cederholm, T., et al. (2017). Carbohydrates and insulin resistance in clinical nutrition: Recommendations from the ESPEN expert group. CLINICAL NUTRITION, 36(2), 355-363 [10.1016/j.clnu.2016.09.010]. Dettagli
  30. Guglielmi, V., & Sbraccia, P. (2017). Epicardial adipose tissue: at the heart of the obesity complications. ACTA DIABETOLOGICA, 54(9), 805-812 [10.1007/s00592-017-1020-z]. Dettagli
  31. Guglielmi, V., & Sbraccia, P. (2017). GLP-1 receptor independent pathways: emerging beneficial effects of GLP-1 breakdown products. EATING AND WEIGHT DISORDERS, 22(2), 231-240 [10.1007/s40519-016-0352-y]. Dettagli
  32. Guglielmi, V., Bellia, A., Pecchioli, S., DELLA MORTE, D., Parretti, D., Cricelli, I., et al. (2017). Effectiveness of adherence to lipid lowering therapy on LDL-cholesterol in patients with very high cardiovascular risk: A real-world evidence study in primary care. ATHEROSCLEROSIS, 263, 36-41 [10.1016/j.atherosclerosis.2017.05.018]. Dettagli
  33. Frühbeck, G., Sbraccia, P., Nisoli, E., Woodward, E., Yumuk, V., Farpour-Lambert, N.j., et al. (2016). 2015 Milan Declaration: A Call to Action on Obesity - an EASO Position Statement on the Occasion of the 2015 EXPO. OBESITY FACTS, 9(4), 296-298-298 [10.1159/000448234]. Dettagli
  34. Arriga, R., Pacifici, F., Capuani, B., Coppola, A., Scioli, M., Pastore, D., et al. (2016). Involvement of PRDX6 in the pathogenesis of obesity and nonalcoholic fatty liver disease. DIABETOLOGIA, 59, S80-S80. Dettagli
  35. Basello, K., Pacifici, F., Capuani, B., Pastore, D., Lombardo, M.f., Ferrelli, F., et al. (2016). Serum- and Glucocorticoid-Inducible Kinase 1 Delay the Onset of Endothelial Senescence by Directly Interacting with Human Telomerase Reverse Transcriptase. REJUVENATION RESEARCH, 19(1), 79-89 [10.1089/rej.2015.1726]. Dettagli
  36. Capuani, B., Pacifici, F., Pastore, D., Palmirotta, R., Donadel, G., Arriga, R., et al. (2016). The role of epsilon PKC in acute and chronic diseases: Possible pharmacological implications of its modulators. PHARMACOLOGICAL RESEARCH, 111, 659-667 [10.1016/j.phrs.2016.07.029]. Dettagli
  37. Guglielmi, V., Bellia, A., Pecchioli, S., Medea, G., Parretti, D., Lauro, D., et al. (2016). What is the actual epidemiology of familial hypercholesterolemia in Italy? Evidence from a National Primary Care Database. INTERNATIONAL JOURNAL OF CARDIOLOGY, 223, 701-705 [10.1016/j.ijcard.2016.08.269]. Dettagli
  38. Guglielmi, V., Floris, R., D'Adamo, M., Garaci, F., Novelli, G., & Sbraccia, P. (2016). Massive obesity and hyperphagia in posterior bilateral periventricular heterotopias: Case report. BMC MEDICAL GENETICS, 17(1), 18 [10.1186/s12881-016-0282-6]. Dettagli
  39. Guglielmi, V., Maresca, L., Lanzillo, C., Marinoni, G.m., D'Adamo, M., Di Roma, M., et al. (2016). Relationship between regional fat distribution and hypertrophic cardiomyopathy phenotype. PLOS ONE, 11(7), e0158892 [10.1371/journal.pone.0158892]. Dettagli
  40. Liguori, C., Mercuri, N.B., Izzi, F., Romigi, A., Cordella, A., Piccirilli, E., et al. (2016). Obstructive sleep apnoea as a risk factor for osteopenia and osteoporosis in the male population. EUROPEAN RESPIRATORY JOURNAL, 47(3), 987-990 [10.1183/13993003.01830-2015]. Dettagli
  41. Santini, F., Busetto, L., Cresci, B., & Sbraccia, P. (2016). SIO management algorithm for patients with overweight or obesity: consensus statement of the Italian Society for Obesity (SIO). EATING AND WEIGHT DISORDERS, 21(2), 305-307 [10.1007/s40519-016-0279-3]. Dettagli
  42. Testa, A., Francesconi, A., Giannuzzi, R., Berardi, S., & Sbraccia, P. (2015). Economic analysis of bedside ultrasonography (US) implementation in an Internal Medicine department. INTERNAL AND EMERGENCY MEDICINE [10.1007/s11739-015-1320-7]. Dettagli
  43. Pastore, D., Della-Morte, D., Coppola, A., Capuani, B., Lombardo, M.f., Pacifici, F., et al. (2015). SGK-1 protects kidney cells against apoptosis induced by ceramide and TNF-α. CELL DEATH & DISEASE, 6 [10.1038/cddis.2015.232]. Dettagli
  44. Guglielmi, V., Cardellini, M., Cinti, F., Corgosinho, F., Cardolini, I., D'Adamo, M., et al. (2015). Omental adipose tissue fibrosis and insulin resistance in severe obesity. NUTRITION & DIABETES, 5(8), e175-e181 [10.1038/nutd.2015.22]. Dettagli
  45. Ferrelli, F., Pastore, D., Capuani, B., Lombardo, M.F., Blot Chabaud, M., Coppola, A., et al. (2015). Serum glucocorticoid inducible kinase (SGK)-1 protects endothelial cells against oxidative stress and apoptosis induced by hyperglycaemia. ACTA DIABETOLOGICA, 52(1), 55-64 [10.1007/s00592-014-0600-4]. Dettagli
  46. CAPUANI, B., DELLA MORTE, D., DONADEL, G., Caratelli, S., Bova, L., PASTORE, D., et al. (2015). Liver protein profiles in insulin receptor-knockout mice reveal novel molecules involved in the diabetes pathophysiology. AMERICAN JOURNAL OF PHYSIOLOGY: ENDOCRINOLOGY AND METABOLISM, 308(9), E744-E755 [10.1152/ajpendo.00447.2014]. Dettagli
  47. Evangelisti, C., Bernasconi, P., Cavalcante, P., Cappelletti, C., D'Apice, M.R., Sbraccia, P., et al. (2015). Modulation of TGFbeta 2 levels by lamin A in U2-OS osteoblast-like cells: Understanding the osteolytic process triggered by altered lamins. ONCOTARGET, 6(10), 7424-7437 [10.18632/oncotarget.3232]. Dettagli
  48. Guglielmi, V., D'Adamo, M., Bellia, A., Ciotto, R., Federici, M., Lauro, D., et al. (2015). Iron status in obesity: An independent association with metabolic parameters and effect of weight loss. NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 25(6), 541-547. Dettagli
  49. Lauro, D., Pastore, D., Capuani, B., Pacifici, F., Palmirotta, R., Abete, P., et al. (2015). Role of serum and glucocorticoid-inducible kinase (SGK)-1 in senescence: a novel molecular target against age-related diseases. CURRENT MEDICINAL CHEMISTRY, 22(33), 3765-3788 [10.2174/0929867322666150812145035]. Dettagli
  50. Lombardo, M., Bellia, A., Mattiuzzo, F., Franchi, A., Ferri, C., Elvira, P., et al. (2015). Frequent Follow-Up Visits Reduce Weight Regain in Long-Term Management after Bariatric Surgery. BARIATRIC SURGICAL PRACTICE AND PATIENT CARE, 10(3), 119-125 [10.1089/bari.2015.0021]. Dettagli
  51. Guglielmi, V., Maresca, L., D'Adamo, M., Di Roma, M., Lanzillo, C., Federici, M., et al. (2014). Age-Related Different Relationships between Ectopic Adipose Tissues and Measures of Central Obesity in Sedentary Subjects. PLOS ONE, 9(7), e103381-e103381 [10.1371/journal.pone.0103381]. Dettagli
  52. Bellia, A., Sallì, M., Lombardo, M., D'Adamo, M., Guglielmi, V., Tirabasso, C., et al. (2014). Effects of whole body vibration plus diet on insulin-resistance in middle-aged obese subjects. INTERNATIONAL JOURNAL OF SPORTS MEDICINE, 35(6), 511-516. Dettagli
  53. Lombardo, M., Bellia, A., Padua, E., Annino, G., Guglielmi, V., D'Adamo, M., et al. (2014). Morning meal more efficient for fat loss in a 3-month lifestyle intervention. JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION, 3(33), 198-205 [10.1080/07315724.2013.863169]. Dettagli
  54. Donini, L., Grave, R., Caretto, A., Lucchin, L., Melchionda, N., Nisoli, E., et al. (2014). From simplicity towards complexity: the Italian multidimensional approach to obesity. EATING AND WEIGHT DISORDERS. Dettagli
  55. Della-Morte, D., Palmirotta, R., Rehni, A.k., Pastore, D., Capuani, B., Pacifici, F., et al. (2014). Pharmacogenomics and pharmacogenetics of thiazolidinediones: Role in diabetes and cardiovascular risk factors. PHARMACOGENOMICS, 15(16), 2063-2082 [10.2217/pgs.14.162]. Dettagli
  56. Montilla, S., Marchesini, G., Sammarco, A., Trotta, M.p., Siviero, P.d., Tomino, C., et al. (2014). Drug utilization, safety, and effectiveness of exenatide, sitagliptin, and vildagliptin for type 2 diabetes in the real world: Data from the Italian AIFA Anti-diabetics Monitoring Registry. NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 24(12), 1346-1353 [10.1016/j.numecd.2014.07.014]. Dettagli
  57. Pacifici, F., Arriga, R., Sorice, G., Capuani, B., Scioli, M., Pastore, D., et al. (2014). Peroxiredoxin 6, a novel player in the pathogenesis of diabetes. DIABETES, 63(10), 3210-3220 [10.2337/db14-0144]. Dettagli
  58. Weedon, M., Ellard, S., Prindle, M., Caswell, R., Lango Allen, H., Oram, R., et al. (2013). An in-frame deletion at the polymerase active site of POLD1 causes a multisystem disorder with lipodystrophy. NATURE GENETICS, 45(8), 947 [10.1038/ng.2670]. Dettagli
  59. Bellia, A., Garcovich, C., D'Adamo, M., Lombardo, M., Tesauro, M., Donadel, G., et al. (2013). Serum 25-hydroxyvitamin D levels are inversely associated with systemic inflammation in severe obese subjects. INTERNAL AND EMERGENCY MEDICINE, 8(1), 33-40 [10.1007/s11739-011-0559-x]. Dettagli
  60. Bellia, A., Rizza, S., Lombardo, M., Donadel, G., Fabiano, R., Andreadi, K., et al. (2012). Deterioration of glucose homeostasis in type 2 diabetic patients one year after beginning of statins therapy. ATHEROSCLEROSIS, 223(1), 197-203 [10.1016/j.atherosclerosis.2012.04.015]. Dettagli
  61. Casagrande, V., Menghini, R., Menini, S., Marino, A., Marchetti, V., Cavalera, M., et al. (2012). Overexpression of tissue inhibitor of metalloproteinase 3 in macrophages reduces atherosclerosis in low-density lipoprotein receptor knockout mice. ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY, 32(1), 74-81 [10.1161/ATVBAHA.111.238402]. Dettagli
  62. Bellia, A., Marinoni, G., D’Adamo, M., Guglielmi, V., Lombardo, M., Donadel, G., et al. (2012). Parathyroid hormone and insulin resistance in distinct phenotypes of severe obesity: a cross-sectional analysis in middle-aged men and premenopausal women. THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 97(12), 4724-4732 [10.1210/jc.2012-2513]. Dettagli
  63. Benedetti, S., Bernasconi, P., Bertini, E., Biagini, E., Capanni, C., Columbaro, M., et al. (2012). The empowerment of translational research: lessons from laminopathies. ORPHANET JOURNAL OF RARE DISEASES, 7(1), 37 [10.1186/1750-1172-7-37]. Dettagli
  64. Menghini, R., Casagrande, V., Menini, S., Marino, A., Marzano, V., Hribal, M., et al. (2012). TIMP3 overexpression in macrophages protects from insulin resistance, adipose inflammation, and nonalcoholic fatty liver disease in mice. DIABETES, 61(2), 454-462 [10.2337/db11-0613]. Dettagli
  65. Cardellini, M., Menghini, R., Luzi, A., Davato, F., Cardolini, I., D'Alfonso, R., et al. (2011). Decreased IRS2 and TIMP3 Expression in Monocytes From Offspring of Type 2 Diabetic Patients Is Correlated With Insulin Resistance and Increased Intima-Media Thickness. DIABETES, 60(12), 3265-3270 [10.2337/db11-0162]. Dettagli
  66. Busetto, L., Sbraccia, P., Frittitta, L., & Pontiroli, A. (2011). The growing role of bariatric surgery in the management of type 2 diabetes: evidences and open questions. OBESITY SURGERY, 21(9), 1451-1457 [10.1007/s11695-011-0471-5]. Dettagli
  67. Fiore, A., Marinoni, G.M., Piccione, A., Marini, M.A., D'Adamo, M., Lauro, R., et al. (2011). A rare cardiac finding in a morbidly obese patient with severe hypertension. INTERNAL AND EMERGENCY MEDICINE, 6(3), 241-244 [10.1007/s11739-010-0472-8]. Dettagli
  68. Rizza, S., Cardellini, M., Porzio, O., Pecchioli, C., Savo, A., Cardolini, I., et al. (2011). Pioglitazone improves endothelial and adipose tissue dysfunction in pre-diabetic CAD subjects. ATHEROSCLEROSIS, 215(1), 180-183 [10.1016/j.atherosclerosis.2010.12.021]. Dettagli
  69. Mammi, C., Pastore, D., Lombardo, M., Ferrelli, F., Caprio, M., Consoli, C., et al. (2011). Sildenafil reduces insulin-resistance in human endothelial cells. PLOS ONE, 6(1), e14542-e14542 [10.1371/journal.pone.0014542]. Dettagli
  70. Shastry, S., Simha, V., Godbole, K., Sbraccia, P., Melancon, S., Yajnik, C.S., et al. (2010). A novel syndrome of mandibular hypoplasia, deafness, and progeroid features associated with lipodystrophy, undescended testes, and male hypogonadism. THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 95(10), E192-E197 [10.1210/jc.2010-0419]. Dettagli
  71. Santilli, F., Formoso, G., Sbraccia, P., Averna, M., Miccoli, R., Di Fulvio, P., et al. (2010). Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 8(4), 828-837 [10.1111/j.1538-7836.2010.03742.x]. Dettagli
  72. Bellia, A., Rizza, S., Galli, A., Fabiano, R., Donadel, G., Lombardo, M.f., et al. (2010). Early vascular and metabolic effects of rosuvastatin compared with simvastatin in patients with type 2 diabetes. ATHEROSCLEROSIS, 210(1), 199-201 [10.1016/j.atherosclerosis.2009.11.021]. Dettagli
  73. Rizza, S., Tesauro, M., Cardillo, C., Galli, A., Iantorno, M., Gigli, F., et al. (2009). Fish oil supplementation improves endothelial function in normoglycemic offspring of patients with type 2 diabetes. ATHEROSCLEROSIS, 206(2), 569-574 [10.1016/j.atherosclerosis.2009.03.006]. Dettagli
  74. Rizza, S., Tesauro, M., Cardillo, C., Galli, A., Iantorno, M., Gigli, F., et al. (2009). Fish oil supplementation improves endothelial function in normoglycemic offspring of patients with type 2 diabetes. ATHEROSCLEROSIS, 206(2), 569-574. Dettagli
  75. Bellia, A., Giardina, E., Lauro, D., Tesauro, M., Di Fede, G., Cusumano, G., et al. (2009). The Linosa Study: epidemiological and heritability data of the metabolic syndrome in a Caucasian genetic isolate. NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 19(7), 455-461 [10.1016/j.numecd.2008.11.002]. Dettagli
  76. Bellia, A., Giardina, E., Lauro, D., Tesauro, M., Di Fede, G., Cusumano, G., et al. (2009). "The Linosa Study": Epidemiological and heritability data of the metabolic syndrome in a Caucasian genetic isolate. NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 19(7), 455-461 [10.1016/j.numecd.2008.11.002]. Dettagli
  77. Rizza, S., Tesauro, M., Cardillo, C., Galli, A., Iantorno, M., Gigli, F., et al. (2009). Fish oil supplementation improves endothelial function in normoglycemic offspring of patients with type 2 diabetes. ATHEROSCLEROSIS, 206(2), 569-574 [10.1016/j.atherosclerosis.2009.03.006]. Dettagli
  78. Lombardi, F., Fasciglione, G., D'Apice, M., Vielle, A., D'Adamo, M., Sbraccia, P., et al. (2008). Increased release and activity of matrix metalloproteinase-9 in patients with mandibuloacral dysplasia type A, a rare premature ageing syndrome. CLINICAL GENETICS, 74(4), 374-383 [10.1111/j.1399-0004.2008.01034.x]. Dettagli
  79. Lombardi, F., Gullotta, F., Columbaro, M., Filareto, A., D'Adamo, M., Vielle, A., et al. (2007). Compound heterozygosity for mutations in LMNA in a patient with a myopathic and lipodystrophic mandibuloacral dysplasia type A phenotype. THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 92(11), 4467-4471 [10.1210/jc.2007-0116]. Dettagli
  80. Serino, M., Menghini, R., Fiorentino, L., Amoruso, R., Mauriello, A., Lauro, D., et al. (2007). Mice heterozygous for tumor necrosis factor-alpha converting enzyme are protected from obesity-induced insulin resistance and diabetes. DIABETES, 56(10), 2541-2546 [10.2337/db07-0360]. Dettagli
  81. Rizza, S., Tesauro, M., Cardellini, M., Menghini, R., Bellia, A., Marini, M., et al. (2006). Insulin resistance and increased intimal medial thickness in glucose tolerant offspring of type 2 diabetic subjects carrying the D298D genotype of endothelial nitric oxide synthase. ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY, 26(2), 431-432 [10.1161/01.ATV.0000196552.84475.fc]. Dettagli
  82. Rizza, S., Tesauro, M., Cardellini, M., Menghini, R., Bellia, A., Marini, M.A., et al. (2006). Insulin resistance and increased intimal medial thickness in glucose tolerant offspring of type 2 diabetic subjects carrying the D298D genotype of endothelial nitric oxide synthase. ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY, 26(2), 431-432 [10.1161/01.ATV.0000196552.84475.fc]. Dettagli
  83. Rizza, S., Tesauro, M., Cardellini, M., Menghini, R., Bellia, A., Marini, M.A., et al. (2006). Insulin resistance and increased intimal medial thickness in glucose tolerant offspring of type 2 diabetic subjects carrying the D298D genotype of endothelial nitric oxide synthase. ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY, 26(2), 431-432 [10.1161/01.ATV.0000196552.84475.fc]. Dettagli
  84. Menghini, R., Marchetti, V., Cardellini, M., Hribal, M., Mauriello, A., Lauro, D., et al. (2005). Phosphorylation of GATA2 by Akt increases adipose tissue differentiation and reduces adipose tissue-related inflammation: a novel pathway linking obesity to atherosclerosis. CIRCULATION, 111(15), 1946-1953 [10.1161/01.CIR.0000161814.02942.B2]. Dettagli
  85. Federici, M., Hribal, M., Menghini, R., Kanno, H., Marchetti, V., Porzio, O., et al. (2005). Timp3 deficiency in insulin receptor-haploinsufficient mice promotes diabetes and vascular inflammation via increased TNF-alpha. THE JOURNAL OF CLINICAL INVESTIGATION, 115(12), 3494-3505 [10.1172/JCI26052]. Dettagli
  86. SBRACCIA P, D.M. (2004). Obesity and anorexia as neuroendocrine disorders.. In C.F. Baldelli R (a cura di), Update in Neuroendocrinology. Pubblicazioni Medico Scientifiche. Dettagli
  87. D'Adamo, M., Perego, L., Cardellini, M., Marini, M.A., Frontoni, S., Andreozzi, F., et al. (2004). The -866A/A genotype in the promoter of the human uncoupling protein 2 gene is associated with insulin resistance and increased risk of type 2 diabetes. DIABETES, 53(7), 1905-1910 [10.2337/diabetes.53.7.1905]. Dettagli
  88. Amati, F., Biancolella, M., D'Apice, M.R., Gambardella, S., Mango, R., Sbraccia, P., et al. (2004). Gene expression profiling of fibroblasts from a human progeroid disease mandibuloacral dysplasia, MAD #248370 through cDNA microarrays. GENE EXPRESSION, 12(1), 39-47. Dettagli
  89. Sesti, G., Cardellini, M., Marini, M., Frontoni, S., D'Adamo, M., Del Guerra, S., et al. (2003). A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects. DIABETES, 52(5), 1280-1283 [10.2337/diabetes.52.5.1280]. Dettagli
  90. Sesti, G., Cardellini, M., Marini, M., Frontoni, S., D'Adamo, M., Del Guerra, S., et al. (2003). A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects. DIABETES, 52(5), 1280-3. Dettagli
  91. Sesti, G., Cardellini, M., Marini, M.A., Frontoni, S., D'Adamo, M., Del Guerra, S., et al. (2003). A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects. DIABETES, 52(5), 1280-1283. Dettagli
  92. Sesti G., C.M. (2003). A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects. DIABETES [10.2337/diabetes.52.5.1280]. Dettagli
  93. Novelli, G., Muchir, A., Sangiuolo, F., Helbling-Leclerc, A., D'Apice, M.R., Massart, C., et al. (2002). Mandibuloacral dysplasia is caused by a mutation in LMNA-encoding lamin A/C. AMERICAN JOURNAL OF HUMAN GENETICS, 71(2), 426-431 [10.1086/341908]. Dettagli
  94. Federici, M., Menghini, R., Mauriello, A., Hribal, M., Ferrelli, F., Lauro, D., et al. (2002). Insulin-dependent activation of endothelial nitric oxide synthase is impaired by O-linked glycosylation modification of signaling proteins in human coronary endothelial cells. CIRCULATION, 106(4), 466-472 [10.1161/​01.CIR.0000023043.02648.51]. Dettagli
  95. Federici, M., Menghini, R., Mauriello, A., Hribal, M.L., Ferrelli, F., Lauro, D., et al. (2002). Insulin-dependent activation of endothelial nitric oxide synthase is impaired by O-linked glycosylation modification of signaling proteins in human coronary endothelial cells. CIRCULATION, 106(4), 466-472 [10.1161/01.CIR.0000023043.02648.51]. Dettagli
  96. Menghini, R., Hribal, M.L., Mauriello, A., Ferrelli, F., Lauro, D., Sbraccia, P., et al. (2002). Hyperglycemia induces pro-atherosclerotic events through O-linked-glycosylation modification of insulin signaling proteins. DIABETES, 51(supp 2), A178-A178. Dettagli
  97. Sbraccia P., D.M. (2002). Relationship between plasma free fatty acids and uncoupling protein-3 gene expression in skeletal muscle of obese subjects: in vitro evidence of a causal link. CLINICAL ENDOCRINOLOGY, 57(2), 199-207 [10.1046/j.1365-2265.2002.01593.x]. Dettagli

    10.1046/j.1365-2265.2002.01593.x

    Citazione
    Sbraccia P., D.M. (2002). Relationship between plasma free fatty acids and uncoupling protein-3 gene expression in skeletal muscle of obese subjects: in vitro evidence of a causal link. CLINICAL ENDOCRINOLOGY, 57(2), 199-207 [10.1046/j.1365-2265.2002.01593.x].
    Data
    2002
    id
    PUBBLICAZIONE_7648
    Tipologia
    Articolo su rivista
    SSD
    Settore MED/49 - Scienze Tecniche Dietetiche Applicate
    Tutti gli Autori
    Relationship between plasma free fatty acids and uncoupling protein-3 gene expression in skeletal muscle of obese subjects: in vitro evidence of a causal link
    tipologia
    Sbraccia P., D'Adamo M., Leonetti F., Buongiorno A., Silecchia G., Basso M.S., Tamburrano G., Lauro D., Federici M., Di Daniele N., Lauro R.
  98. Sesti, G., Federici, M., Hribal, M., Lauro, D., Sbraccia, P., & Lauro, R. (2001). Defects of the insulin receptor substrate (IRS) system in human metabolic disorders. THE FASEB JOURNAL, 15(12), 2099-2111 [10.1096/fj.01-0009rev]. Dettagli
  99. Sesti, G., Federici, M., Hribal, M.l., Lauro, D., Sbraccia, P., & Lauro, R. (2001). Defects of the insulin receptor substrate (IRS) system in human metabolic disorders. THE FASEB JOURNAL, 15(12), 2099-2111 [10.1096/fj.01-0009rev]. Dettagli
  100. Frittitta, L., Sbraccia, P., Costanzo, B.V., Tassi, V., D'Adamo, M., Spampinato, D., et al. (2000). High insulin levels do not influence PC-1 gene expression and protein content in human muscle tissue and hepatoma cells. DIABETES/METABOLISM RESEARCH AND REVIEWS, 16(1), 26-32. Dettagli
  101. Giovannone, B., Scaldaferri, M., Federici, M., Porzio, O., Lauro, D., Fusco, A., et al. (2000). Insulin receptor substrate (IRS) transduction system: Distinct and overlapping signaling potential. DIABETES/METABOLISM RESEARCH AND REVIEWS, 16(6), 434-441 [10.1002/1520-7560(2000)9999:9999<::AID-DMRR159>3.0.CO;2-8]. Dettagli
  102. Federici, M., Lauro, D., D'Adamo, M., Giovannone, B., Porzio, O., Mellozzi, M., et al. (1998). Expression of insulin/IGF-I hybrid receptors is increased in skeletal muscle of patients with chronic primary hyperinsulinemia. DIABETES, 47(1), 87-92. Dettagli
  103. D'Adamo, M., Buongiorno, A., Maroccia, E., Leonetti, F., Barbetti, F., Giaccari, A., et al. (1998). Increased OB gene expression leads to elevated plasma leptin concetrations in patients with chronic primary hyperinsulinemia. DIABETES. Dettagli
  104. Barbetti, F., Rocchi, M., Bossolasco, M., Cordera, R., Sbraccia, P., Finelli, P., et al. (1996). The human skeletal muscle glycogenin gene: cDNA, tissue expression, and chromosomal localization. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 220(1), 72-77 [10.1006/bbrc.1996.0359]. Dettagli